Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandy Srinivas

Showing results (11-20 of 153) with videos related to

Pageof 16
Sort By:
Chemotherapy|July 31, 2009
A phase II study of docetaxel and oxaliplatin for second-line treatment of urothelial carcinomaSandy Srinivas, Lauren C Harshman
BJU International|August 18, 2005
A lower dose of thalidomide is better than a high dose in metastatic renal cell carcinomaSandy Srinivas, Alice E Guardino
Oncotargets and Therapy|November 5, 2010
The bevacizumab experience in advanced renal cell carcinomaLauren C Harshman, Sandy Srinivas
Expert Review of Anticancer Therapy|December 8, 2007
Current status of cytoreductive nephrectomy in metastatic renal cell carcinomaLauren C Harshman, Sandy Srinivas
Onkologie|October 6, 2012
Variations in normal serum alpha-fetoprotein (AFP) levels in patients with testicular cancer on surveillancePriti Patel, Raymond Balise, Sandy Srinivas
Urology|October 20, 2004
Synchronous solitary metastasis of transitional cell carcinoma of the bladder to the testisKelly Morgan, Sandy Srinivas, Fuads Freiha
Nature Reviews. Urology|December 9, 2015
Androgen-glucocorticoid interactions in the era of novel prostate cancer therapySujata Narayanan, Sandy Srinivas, David Feldman
Hematology/Oncology Clinics of North America|April 4, 2015
Second-line therapies in metastatic urothelial carcinomaSujata Narayanan, Lauren C Harshman, Sandy Srinivas
Dermato-Endocrinology|January 5, 2010
Inhibition of prostaglandin synthesis and actions contributes to the beneficial effects of calcitriol in prostate cancerAruna V Krishnan, Sandy Srinivas, David Feldman
Archives of Surgery (Chicago, Ill. : 1960)|September 7, 2002
Positron emission tomography in the initial staging of esophageal cancerSherry M Wren, Pascal Stijns, Sandy Srinivas
Pageof 16

Showing results (11-20 of 153) with videos related to

Sort By:
Pageof 16
Chemotherapy|July 31, 2009
A phase II study of docetaxel and oxaliplatin for second-line treatment of urothelial carcinomaSandy Srinivas, Lauren C Harshman
BJU International|August 18, 2005
A lower dose of thalidomide is better than a high dose in metastatic renal cell carcinomaSandy Srinivas, Alice E Guardino
Oncotargets and Therapy|November 5, 2010
The bevacizumab experience in advanced renal cell carcinomaLauren C Harshman, Sandy Srinivas
Expert Review of Anticancer Therapy|December 8, 2007
Current status of cytoreductive nephrectomy in metastatic renal cell carcinomaLauren C Harshman, Sandy Srinivas
Onkologie|October 6, 2012
Variations in normal serum alpha-fetoprotein (AFP) levels in patients with testicular cancer on surveillancePriti Patel, Raymond Balise, Sandy Srinivas
Urology|October 20, 2004
Synchronous solitary metastasis of transitional cell carcinoma of the bladder to the testisKelly Morgan, Sandy Srinivas, Fuads Freiha
Nature Reviews. Urology|December 9, 2015
Androgen-glucocorticoid interactions in the era of novel prostate cancer therapySujata Narayanan, Sandy Srinivas, David Feldman
Hematology/Oncology Clinics of North America|April 4, 2015
Second-line therapies in metastatic urothelial carcinomaSujata Narayanan, Lauren C Harshman, Sandy Srinivas
Dermato-Endocrinology|January 5, 2010
Inhibition of prostaglandin synthesis and actions contributes to the beneficial effects of calcitriol in prostate cancerAruna V Krishnan, Sandy Srinivas, David Feldman
Archives of Surgery (Chicago, Ill. : 1960)|September 7, 2002
Positron emission tomography in the initial staging of esophageal cancerSherry M Wren, Pascal Stijns, Sandy Srinivas
Pageof 16